Sauer Kerstin A, Maxeiner Joachim H, Karwot Roman, Scholtes Petra, Lehr Hans A, Birkenbach Mark, Blumberg Richard S, Finotto Susetta
Laboratory of Cellular and Molecular Immunology of the Lung, I. Medical Clinic, University of Mainz, Germany.
J Immunol. 2008 Nov 1;181(9):6148-57. doi: 10.4049/jimmunol.181.9.6148.
EBV-induced gene 3 (EBI-3) codes for a soluble type I receptor homologous to the p40 subunit of IL-12 that is expressed by APCs following activation. In this study, we assessed the role of EBI-3 in a model of lung melanoma metastasis. Intravenous injection of the B16-F10 cell line resulted in a significant reduction of lung tumor metastasis in EBI-3(-/-) recipient mice compared with wild-type mice. The immunological finding accompanying this effect was the expansion of a newly described cell subset called IFN-gamma producing killer dendritic cells associated with CD8(+) T cell responses in the lung of EBI-3(-/-) mice including IFN-gamma release and TNF-alpha-induced programmed tumor cell death. Depletion of CD8(+) T cells as well as targeting T-bet abrogated the protective effects of EBI-3 deficiency on lung melanoma metastases. Finally, adoptive transfer of EBI-3(-/-) CD8(+) T cells into tumor bearing wild-type mice inhibited lung metastasis in recipient mice. Taken together, these data demonstrate that targeting EBI-3 leads to a T-bet-mediated antitumor CD8(+) T cell responses in the lung.
EB病毒诱导基因3(EBI-3)编码一种可溶性I型受体,与白细胞介素12的p40亚基同源,在激活后由抗原呈递细胞(APC)表达。在本研究中,我们评估了EBI-3在肺黑色素瘤转移模型中的作用。与野生型小鼠相比,静脉注射B16-F10细胞系导致EBI-3基因敲除(EBI-3(-/-))受体小鼠的肺肿瘤转移显著减少。伴随这种效应的免疫学发现是一种新描述的细胞亚群的扩增,即产生γ干扰素的杀伤性树突状细胞,其与EBI-3(-/-)小鼠肺中的CD8(+) T细胞反应相关,包括γ干扰素释放和肿瘤坏死因子α诱导的程序性肿瘤细胞死亡。去除CD8(+) T细胞以及靶向T-bet消除了EBI-3缺陷对肺黑色素瘤转移的保护作用。最后,将EBI-3(-/-) CD8(+) T细胞过继转移到荷瘤野生型小鼠中可抑制受体小鼠的肺转移。综上所述,这些数据表明靶向EBI-3可导致肺中T-bet介导的抗肿瘤CD8(+) T细胞反应。
J Clin Invest. 2020-11-2
Front Oncol. 2019-10-1
Immunohorizons. 2019-1-15
Immunity. 2019-4-16
Proc Natl Acad Sci U S A. 2019-2-4
J Immunol. 2008-6-15
J Allergy Clin Immunol. 2008-4
Nature. 2007-11-22
Nature. 2007-2-22